Neurology · 2013 · 190 citations · 37 references
MedicineNeurologyNeuroscienceNeurochemistrySleep MedicineSleep NeurologyGlutamatergic NeurochemistryGlutamatergic SignalingRestless Legs SyndromeSleep PhysiologySleep-wake DisordersSleep-wake NeurobiologyGlutamatergic NeuronsGlutamatergic NeurotransmissionGlutamatergic SynapsesGlutamine MetabolismNocturnal ArousalRestless Legs Syndrome PathophysiologyThalamocortical Glutamatergic Signaling
Objective: To evaluate possible abnormal increase in thalamic glutamate/glutamine levels for restless legs syndrome (RLS) indicating increased glutamatergic activity producing arousal that at night disrupts and shortens sleep. Methods: 1H MRS of the right thalamus was performed using a 1.5 T GE MRI scanner and the PROBE-P (PRESS) on 28 patients with RLS and 20 matched controls. The Glx signal (combination of mostly glutamate [Glu] and glutamine [Gln]) was assessed as a ratio to the total creatine (Cr). This study tested 2 primary hypotheses: 1) higher thalamic Glx/Cr for patients with RLS than controls; 2) thalamic Glx/Cr correlates with increased wake during the sleep period. Results: The Glx/Cr was higher for patients with RLS than controls (mean ± SD 1.20 ± 0.73 vs 0.80 ± 0.39, t = 2.2, p = 0.016) and correlated significantly with the wake time during the sleep period ( r = 0.61, p = 0.007) and all other RLS-related polysomnographic sleep variables ( p < 0.05) except for periodic leg movements during sleep (PLMS)/hour. Conclusions: The primary findings introduce 2 new related dimensions to RLS: abnormalities in a major nondopaminergic neurologic system and the arousal disturbance of sleep. The strong relation of the arousal sleep disturbance to glutamate and the lack of relation to the PLMS motor features of RLS contrasts with the reverse for dopamine of a limited relation to arousal sleep disturbance but strong relation to PLMS. Understanding this dichotomy and the interaction of these 2 differing systems may be important for understanding RLS neurobiology and developing better treatments for RLS. Cho= : choline-containing compounds; Cr= : creatine/phosphocreatine; Gln= : glutamine; Glu= : glutamate; Glx= : glutamine plus glutamate; 1H MRS= : proton magnetic resonance spectroscopy; mI= : myo-inositol; NAA= : N -acetylaspartate; PLMS= : periodic leg movements during sleep; PSG= : polysomnography; RLS= : restless legs syndrome; SWS= : slow-wave sleep; VMB= : ventral midbrain; WDSP= : wake during the sleep period
37
Simplified Statistics for Small Numbers of Observations
Rochelle Dean, W. J. Dixon · Analytical Chemistry · 1951 · 937 citations
MRI measurement of brain iron in patients with restless legs syndrome
Richard P. Allen, Peter B. Barker, F. Wehrl et al. · Neurology · 2001 · 566 citations
Medicine, Neurology, Neuroscience +16
Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome
James R. Connor, Philip J. Boyer, Sharon Menzies et al. · Neurology · 2003 · 542 citations
Medicine, Neurology, Neuroscience +17